The net result of these actions is down-regulation of AR function, as demonstrated by slowed cell cycle progression and down-regulation of endogenous PSA (prostate specific antigen) expression, an AR target gene utilized clinically to monitor prostate cancer growth and recurrence [98]. The gene discussed is AR; the disease is prostate carcinoma.